BG Medicine to Find Biomarkers, Study Drug Effects in Deal with Boehringer Ingelheim

Jul 28, 2005

NEW YORK, July 28 (GenomeWeb News) - Using its systems pharmacology platform, BG Medicine will examine the effects of drugs in tissue and discover plasma biomarkers in an agreement with Boehringer Ingelheim Pharmaceuticals, the companies said today in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Dual Listings Sought

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

Allocating the Grant Pie

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

More Proposed for NSF

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

This Week in PNAS

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.

Main menu